Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

Fig. 4

Lymphocyte subgroups with pre-vaccination (day 0) and post-vaccination (day 14, 21, and 28) as by flow cytometry. a The bar graph represent mean ± standard deviation (n = 15). The percentages of CD3+CD4+T cells,CD3+CD8+ T cell, CD3+CD56+ natural killer T (NKT) cell, CD3+Vα24+ iNKT cell, and CD3CD16+CD56+ NK cell populations were not significantly increased (p > 0.05). The percentage of CD3+CD4+CD25+Foxp3+ T regulatory cells (Tregs) population was significantly decreased starting from day 14 (*, p < 0.05). b Representative dot plot (gated on CD3+CD4+CD25+) of CD3+CD4+CD25+Foxp3+ Tregs of post-and pre-vaccination

Back to article page